Business Wire

Meitheal Pharmaceuticals Secures Exclusive Commercial Licensing Agreement for Three Biosimilars in the U.S.

CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated biopharmaceutical company based in Chicago and focused on the development and commercialization of generic ...

Path Fertility Releases its Company Facts Sheet

SALT LAKE CITY, UT / ACCESS Newswire / March 10, 2026 / Path FertilityTM, an epigenetics-driven fertility technology ...

For Couples in “Fertility Limbo,” a Real-World Study Published by JARG Finds “Normal” Semen Analysis May Not Tell the Whole Story

A peer-reviewed, multi-clinic study published in the Journal of Assisted Reproduction and Genetics suggests an ...
Business Wire

Meitheal Pharmaceuticals Expands Specialty Biopharmaceuticals Portfolio with Acquisition of CONTEPO™ (Fosfomycin for Injection) from Nabriva Therapeutics

CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated biopharmaceutical company based in Chicago and focused on the development and commercialization of generic ...
Benzinga.com

Celmatix Nominates First Lead Compound in Oral Fertility Drug Program

Dr. Piraye Yurttas Beim, Founder and CEO of Celmatix, stated, "Our oral FSH program stands to fundamentally change the landscape of fertility treatments. By offering a non-invasive alternative to ...